We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.
Lilly SANADNA icône

1.1 by Eli Lilly and Company


Oct 31, 2017

À propos de Lilly SANADNA

Français

An initiative to provide educational information to fight against osteoporosis.

Lilly SANADNA app is an initiative created by Eli Lilly & Company in the Middle East as part of its commitment towards providing patients and health care providers the necessary support they need to fight against osteoporosis.

It would allow integrating different patient support services for better awareness, adherence & outcomes. The proposed solution consists of configurable selections from mobile app.

• Patient- Allows user to view educational videos, get adherence reminders and contact MEs

• Caregiver- Patients give access to caregivers for similar functionalities as patients

• HCP- Get adherence reports of their patients to close the loop

• Nurse- HCP provide access to nurses; similar functionalities as HCP

• ME- Tag patients to Brand Tracker categories and see adherence of their patients

• Pharmacist- View disease and product related content

Quoi de neuf dans la dernière version 1.1

Last updated on Oct 31, 2017

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Chargement de la traduction...

Informations Application supplémentaires

Dernière version

Demande Lilly SANADNA mise à jour 1.1

Nécessite Android

4.2 and up

Voir plus

Lilly SANADNA Captures d'écran

Charegement du commentaire...
Langues
Abonnez-vous à APKPure
Soyez le premier à avoir accès à la sortie précoce, aux nouvelles et aux guides des meilleurs jeux et applications Android.
Non merci
S'inscrire
Abonné avec succès!
Vous êtes maintenant souscrit à APKPure.
Abonnez-vous à APKPure
Soyez le premier à avoir accès à la sortie précoce, aux nouvelles et aux guides des meilleurs jeux et applications Android.
Non merci
S'inscrire
Succès!
Vous êtes maintenant souscrit à notre newsletter.